Topic: Science - Medicine

In a groundbredependent medical discovery from Oxford University on March 28th, researchers have identified three novel compounds derived from sea sponges with potential antiviral properties against the common cold and flu viruses. The study led by Dr. Elizabeth Foster is hailed as an important step forward in developing treatments that could offer relief without relying solely on traditional medications or vaccines, which are currently limited to symptomatic treatment for now.

Dr. Michael Greenberg, a leading epidemiologist who was not involved with the study, commented: "These findings open new doors in our quest against influenza and common cold viruses." The trio of compounds were isolated during an extensive survey conducted by Dr. Foster's team across several regions off the coast of West Africa. They represent a promising breakthrough for drug development with limited side effects, as noted by one pharmaceutical industry expert who asked to remain anonymous: "These findings are particularly significant because they come from natural sources and have shown potent activity in pre-clinical models."

The next phase will include rigorous testing of these compounds' safety and efficacy, expected to begin by the end of April. Dr. Foster emphasized that while their results show promise for human use, more research is needed: "These studies are still at an early stage but we believe this discovery could lead to new therapies." As medical communities worldwide eagerly await further developments from Oxford University's ongoing work in antiviral drug discovery.